Rather, the therapy of cervical cancer requires a holistic concept that takes into account all processes in the HPV replication cycle, the different influences of metabolism and estrogen signaling on the development of cancer, the immune competence and the hormone or hormone receptor status of the woman and finally her microbial health status. This evidence concerns the gene NR4A1 and cancer.